Related Experiment Video
Updated: Mar 26, 2026
06:59
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
31.5K
Incorporating Pharmacy Scholarship to Management Responsibilities
John B Hertig1, Robert J Weber2
1Center for Medication Safety Advancement, Purdue University College of Pharmacy , Indianapolis, Indiana.
Hospital Pharmacy
|January 30, 2016
Summary
Pharmacy leaders can advance innovation by building scholarship into their workflow. Applying project management principles can overcome barriers to publishing and presenting scholarly work.
Area of Science:
- Pharmacy Practice
- Healthcare Management
- Scholarly Communication
Background:
- Professional advancement in pharmacy requires innovation and collaboration.
- Scholarship, including publications and presentations, is key to advancing pharmacy practice.
- Pharmacy leaders face challenges in integrating scholarly activities into demanding schedules.
Purpose of the Study:
- To provide recommendations for pharmacy leaders to incorporate scholarly work into their roles.
- To outline strategies for overcoming barriers to scholarship for pharmacy leaders.
- To encourage the dissemination of successful pharmacy innovations through scholarly channels.
Main Methods:
- The column outlines practical recommendations for pharmacy leaders.
- It suggests applying project management principles to scholarly endeavors.
- Identifying and supporting projects for publication or presentation is recommended.
Main Results:
- Integrating scholarship can lead to the sharing of best practices.
- Overcoming scheduling barriers allows for greater contribution to professional literature.
- Proactive management of scholarly activities enhances innovation dissemination.
Conclusions:
- Pharmacy leaders are encouraged to prioritize and integrate scholarship.
- Effective incorporation of scholarship drives innovation and best practice sharing.
- Project management strategies can facilitate leaders' scholarly contributions.
Related Concept Videos
01:26Pharmaceutical Poisoning: Potential Scenarios
76
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
76
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
71
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
71
01:28Biopharmaceutics and Pharmacokinetics: Overview
5.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
5.0K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
646
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
646
01:26Drug Administration and Therapy Phases: Overview
1.7K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.7K
01:25Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
355
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
355